Clinical Study on the Correlation Between IMR(Index of Microcirculation Resistance) and FFR(Fractional Flow Reserve)
NCT ID: NCT04224714
Last Updated: 2020-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2019-09-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)
NCT01621438
Predictive Value of Combining AccuIMR and AccuFFR in Patients With STEMI
NCT06435728
Pd/Pa vs iFR™ in an Unselected Population Referred for Invasive Angiography
NCT02377310
Fractional Flow Reserve (FFR) Versus Instant Wave-Free Ratio (iFR)
NCT01559493
Quantitative Fractional Ratio-guided Revascularization in STEMI Patients With Multi-vessel Disease
NCT04259853
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coronary heart disease patient
Quantitative coronary angiography (QCA) showed that there was a critical lesion in the proximal or middle segment of the coronary artery (diameter stenosis rate was 50% - 70%), and the diameter of the artery was more than 2.5mm
FFR
FFR measurement: Pressure guid wire(radianalyzer Xpress 12711) is produced in Switzerland. After the pressure of the aorta and the pressure guide wire is balanced, Send the pressure guide wire to the distal part of the lesion(more than 20 mm away from the lesion) . Adenosine is injected into the vein,then,record the FFR index 3 times and take the average value as the final measurement index.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FFR
FFR measurement: Pressure guid wire(radianalyzer Xpress 12711) is produced in Switzerland. After the pressure of the aorta and the pressure guide wire is balanced, Send the pressure guide wire to the distal part of the lesion(more than 20 mm away from the lesion) . Adenosine is injected into the vein,then,record the FFR index 3 times and take the average value as the final measurement index.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
(3) Agree to participate in the study and sign informed consent
\-
Exclusion Criteria
(3) With severe heart failure (NYHA cardiac function grade ≥ grade III or left ventricular ejection fraction \< 35%);
(4) Patients with less than 1 year of stent implantation or with coronary artery bypass grafting;
(5) Patients with left main lesion, severe distorted calcification, open lesion, bifurcated lesion or complete occlusion;
(6) Patients with severe hepatorenal insufficiency;
(7) Contraindications to adenosine, aspirin and clopidogrel;
(8) Patients with advanced tumor or life expectancy less than 1 year;
(9) Patients with severe asthma or uncontrolled asthma;
(10) Women in pregnancy.
\-
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The People's Hospital of Liaoning Province
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhilin Miao
Chief physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The people's hospital of LiaoNing Province
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTC-91616
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.